We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

56 hedge funds and large institutions have $39.9M invested in Sio Gene Therapies Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $787K | Put options by funds: $395K

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

4% more funds holding

Funds holding: 54 → 56 (+2)

31% less capital invested

Capital invested by funds: $57.7M → $39.9M (-$17.8M)

Holders
56
Holders Change
+2
Holders Change %
+3.7%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
12
Closed
7
Calls
$787K
Puts
$395K
Net Calls
+$392K
Net Calls Change
+$387K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.77M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$954K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$638K
4
PM
Prosight Management
Texas
+$516K
5
BCM
Bridgeway Capital Management
Texas
+$251K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$8.11M
2
OM
Opaleye Management
Massachusetts
-$2.27M
3
TVWM
Tower View Wealth Management
Wisconsin
-$1.6M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$464K
5
Two Sigma Investments
Two Sigma Investments
New York
-$418K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$121K -$65.5K -30,101 -35%
Primecap Management
27
Primecap Management
California
$112K -$1.14K -525 -1%
Marshall Wace
28
Marshall Wace
United Kingdom
$103K +$103K +47,537 New
Simplex Trading
29
Simplex Trading
Illinois
$87K – – –
AC
30
Apogem Capital
New York
$86K +$43.6K +20,041 +103%
PCM
31
Prelude Capital Management
New York
$74K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$60K +$28.1K +12,937 +88%
ECM
33
ExodusPoint Capital Management
New York
$46K -$38.3K -17,600 -45%
Bank of America
34
Bank of America
North Carolina
$46K +$46.2K +21,238 +106,190%
Charles Schwab
35
Charles Schwab
California
$44K – – –
Verition Fund Management
36
Verition Fund Management
Connecticut
$43K – – –
Ameriprise
37
Ameriprise
Minnesota
$32K – – –
TSS
38
Two Sigma Securities
New York
$28K +$28.4K +13,061 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$27K – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$26K +$25.9K +11,920 New
TRCT
41
Tower Research Capital (TRC)
New York
$20K +$19.9K +9,161 +9,070%
SM
42
SG3 Management
Puerto Rico
$20K +$20.1K +9,230 New
MAM
43
Meeder Asset Management
Ohio
$6K +$72 +33 New
TWA
44
TCI Wealth Advisors
Arizona
$3K +$3.04K +1,400 New
JP Morgan Chase
45
JP Morgan Chase
New York
$2K -$8.85K -4,071 -80%
CAPTRUST Financial Advisors
46
CAPTRUST Financial Advisors
North Carolina
$2K – – –
Wells Fargo
47
Wells Fargo
California
$2K +$159 +73 +10%
EWM
48
Edge Wealth Management
New York
$1K – – –
FWM
49
Focused Wealth Management
New York
$1K – – –
WWM
50
Wolff Wiese Magana
California
$1K – – –
1
2
3

SIOX Hedge Fund Activity: Q3 2021 in Review

56 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q3 2021, worth a combined $39.9M — down 31% from $57.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SIOX positions and 7 closed out — a net gain of 3 holders — while 15 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.77M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $8.11M sold.

  • 56 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q3 2021, up from 54 in Q2 2021.
  • Funds reported $39.9M of Sio Gene Therapies Inc. Common Stock stock for Q3 2021, down 31% quarter-over-quarter.
  • 10 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q3 2021 and 7 closed out, a net change of +3 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q3 2021 was Renaissance Technologies, an estimated $1.77M added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q3 2021 was Consonance Capital Management, an estimated $8.11M sold.

Based on aggregated 13F filings for Q3 2021.